This grant is designed to establish a robust and adaptable network infrastructure to significantly advance cancer prevention and interception efforts. It aims to facilitate collaborative research focused on discovering novel molecularly or immunologically targeted agents. These agents are specifically developed to prevent or interrupt the progression of oncogenic processes within high-risk populations. The overarching purpose of this grant is to drive the development of innovative, precision-based strategies for cancer prevention, ultimately leading to more effective interventions that reduce cancer incidence and improve outcomes for vulnerable individuals at risk of developing cancer.
Opportunity ID: 343505
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-22-055 |
Funding Opportunity Title: | Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 13, 2022 |
Last Updated Date: | Sep 13, 2022 |
Original Closing Date for Applications: | Nov 21, 2022 |
Current Closing Date for Applications: | Nov 21, 2022 |
Archive Date: | Dec 27, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $720,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Private institutions of higher education City or township governments For profit organizations other than small businesses County governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The overall goal of this FOA is to establish an agile and effective network infrastructure that undertakes collaborative research to discover molecularly or immunologically targeted agents designed to prevent or intercept oncogenic process in high-risk populations for precision cancer prevention and interception. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-055.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 343505 Full Announcement-RFA-CA-22-055 -> RFA-CA-22-055-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276789 | Oct 21, 2022 | Nov 21, 2022 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277511 | Oct 27, 2022 | Nov 21, 2022 | View |
Package 1
Mandatory forms
343505 RR_SF424_5_0-5.0.pdf
343505 PHS398_CoverPageSupplement_5_0-5.0.pdf
343505 RR_OtherProjectInfo_1_4-1.4.pdf
343505 PerformanceSite_4_0-4.0.pdf
343505 RR_KeyPersonExpanded_4_0-4.0.pdf
343505 PHS398_ResearchPlan_4_0-4.0.pdf
343505 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343505 PHS_Additional_IndirectCosts_2_0-2.0.pdf
343505 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343505 RR_SF424_5_0-5.0.pdf
343505 PHS398_CoverPageSupplement_5_0-5.0.pdf
343505 RR_OtherProjectInfo_1_4-1.4.pdf
343505 PerformanceSite_4_0-4.0.pdf
343505 RR_KeyPersonExpanded_4_0-4.0.pdf
343505 PHS398_ResearchPlan_5_0-5.0.pdf
343505 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343505 PHS_Additional_IndirectCosts_2_0-2.0.pdf
343505 PHS_AssignmentRequestForm_3_0-3.0.pdf